Dulanermin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Dulanermin, covering 2011-10-07 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer [Phase 1]